↓ Skip to main content

Cochrane Database of Systematic Reviews

Addition to inhaled corticosteroids of long‐acting beta2‐agonists versus anti‐leukotrienes for chronic asthma

Overview of attention for article published in Cochrane database of systematic reviews, January 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

policy
4 policy sources
twitter
28 X users
facebook
1 Facebook page
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
96 Dimensions

Readers on

mendeley
367 Mendeley
citeulike
1 CiteULike
Title
Addition to inhaled corticosteroids of long‐acting beta<sub>2</sub>‐agonists versus anti‐leukotrienes for chronic asthma
Published in
Cochrane database of systematic reviews, January 2014
DOI 10.1002/14651858.cd003137.pub5
Pubmed ID
Authors

Bhupendrasinh F Chauhan, Francine M Ducharme

Abstract

Asthma patients who continue to experience symptoms despite taking regular inhaled corticosteroids (ICS) represent a management challenge. Long-acting beta2-agonists (LABA) and anti-leukotrienes (LTRA) are two treatment options that could be considered as add-on therapy to ICS.

X Demographics

X Demographics

The data shown below were collected from the profiles of 28 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 367 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
United Kingdom 1 <1%
Japan 1 <1%
Denmark 1 <1%
Unknown 362 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 50 14%
Student > Bachelor 40 11%
Researcher 29 8%
Student > Ph. D. Student 29 8%
Other 22 6%
Other 73 20%
Unknown 124 34%
Readers by discipline Count As %
Medicine and Dentistry 111 30%
Nursing and Health Professions 44 12%
Pharmacology, Toxicology and Pharmaceutical Science 20 5%
Social Sciences 11 3%
Agricultural and Biological Sciences 10 3%
Other 37 10%
Unknown 134 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2023.
All research outputs
#1,347,912
of 26,316,305 outputs
Outputs from Cochrane database of systematic reviews
#2,681
of 13,209 outputs
Outputs of similar age
#14,471
of 324,482 outputs
Outputs of similar age from Cochrane database of systematic reviews
#54
of 248 outputs
Altmetric has tracked 26,316,305 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,209 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.8. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 324,482 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 248 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.